TMEM259

Across TCGA pan-cancer cohorts, TMEM259 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TMEM259 data layer compared with 27 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher TMEM259 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated TMEM259 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

CCRCC, LUAD, and HNSC are the cancer types where TMEM259 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.690	0.904	.003	28	view →
LUAD	DFS	Tertile	All	0.632	1.000	.010	12	view →
HNSC	DFS	Quartile	All	0.989	0.861	.015	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TMEM259–CCRCC (DFS)

Open the CCRCC breakdown →